UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 8, pp. 763 - 772
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Pleural Neoplasms - surgery | Male | Treatment Outcome | Combined Modality Therapy | Pneumonectomy | Feasibility Studies | Disease-Free Survival | Mesothelioma - radiotherapy | Mesothelioma - surgery | Pleural Neoplasms - radiotherapy | Adult | Female | Aged | Care and treatment | Management science | Patient outcomes | Oncology, Experimental | Clinical trials | Mesothelioma | Research | Cancer | Index Medicus
Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 03/2016, Volume 11, Issue 3, pp. 380 - 390
Brain metastases | Afatinib | NSCLC | Epidermal growth factor receptor | Respiratory System | Oncology | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Brain Neoplasms - secondary | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Aged, 80 and over | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Brain Neoplasms - enzymology | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Brain Neoplasms - genetics | Treatment Outcome | Brain Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 27, pp. 3342 - 3350
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Pneumology | Lung Neoplasms - drug therapy | Adenocarcinoma - pathology | Adenocarcinoma of Lung | Glutamates - adverse effects | Guanine - analogs & derivatives | Humans | ErbB Receptors - genetics | Lung Neoplasms - pathology | Cisplatin - administration & dosage | Adenocarcinoma - genetics | Guanine - adverse effects | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Adenocarcinoma - enzymology | Treatment Outcome | Adenocarcinoma - drug therapy | Pemetrexed | Afatinib | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Cisplatin - adverse effects | Glutamates - administration & dosage | Quality of Life | Mutation | Neoplasm Staging | Guanine - administration & dosage | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 141 - 151
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Cisplatin - administration & dosage | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Lung Neoplasms - genetics | Deoxycytidine - administration & dosage | Survival Rate | Mutation - genetics | Adenocarcinoma - drug therapy | Pemetrexed | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - therapeutic use | Glutamates - administration & dosage | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Guanine - administration & dosage | Adenocarcinoma | Antimitotic agents | Chemotherapy | Lung cancer | Analysis | Genetic aspects | Antineoplastic agents | Cancer | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 577 - 589
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma, Non-Small-Cell Lung - pathology | Receptor, Epidermal Growth Factor - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Protein Kinase Inhibitors - adverse effects | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Drug-Related Side Effects and Adverse Reactions - genetics | Quinazolines - adverse effects | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Drug-Related Side Effects and Adverse Reactions - physiopathology | Drug-Related Side Effects and Adverse Reactions - classification | Tyrosine | Clinical trials | Medical colleges | Care and treatment | Lung cancer, Non-small cell | Gefitinib | Analysis | Index Medicus | Medicin och hälsovetenskap
Journal Article
6.
Full Text
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
American journal of human genetics, ISSN 0002-9297, 11/2017, Volume 101, Issue 5, pp. 664 - 685
NTRK2 | GABRB2 | GABBR2 | NUS1 | RAB11 | SNAP25 | CLTC | epileptic encephalopathy | DHDDS | Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Recurrence | Seizures - genetics | Humans | Brain Diseases - genetics | Child, Preschool | Male | Mutation - genetics | Genome, Human - genetics | Intellectual Disability - genetics | Epilepsy - genetics | Female | Genome-Wide Association Study - methods | Child | Index Medicus | Life Sciences | Human health and pathology
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 27, pp. 3327 - 3334
Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Adenocarcinoma - pathology | Adenocarcinoma of Lung | Cisplatin - pharmacokinetics | Glutamates - adverse effects | Guanine - analogs & derivatives | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | ErbB Receptors - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Quinazolines - pharmacokinetics | Lung Neoplasms - pathology | Male | Cisplatin - administration & dosage | Neoplasm Metastasis | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Guanine - adverse effects | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Guanine - pharmacokinetics | Adenocarcinoma - enzymology | Glutamates - pharmacokinetics | Adenocarcinoma - drug therapy | Pemetrexed | Afatinib | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Cisplatin - adverse effects | Glutamates - administration & dosage | Aged | Mutation | Guanine - administration & dosage | Index Medicus
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2015, Volume 137, Issue 1, pp. 75 - 86.e8
Allergy and Immunology | severe asthma | eosinophilic bronchitis | Group 2 innate lymphoid cells | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Sputum - cytology | Humans | Middle Aged | Male | Immunity, Innate | Interleukin-5 - blood | Young Adult | Lymphocytes - immunology | Asthma - blood | Asthma - immunology | Adult | Female | Interleukin-13 - blood | Pulmonary Eosinophilia - blood | Pulmonary Eosinophilia - immunology | Corticosteroids | Eosinophilia | Statistics | Analysis | Asthma | Studies | Airway management | Inflammation | Disease | Cytokines | Index Medicus | Abridged Index Medicus
Journal Article